Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,882Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Strides Pharma Science

02 9Gilead Sciences

03 1Orbit Lifescience

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Ledipasvir; Sofosbuvir

Brand Name :

Dosage Form : Tablet

Dosage Strength : 90MG; 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LEDIPASVIR; SOFOSBUVIR

Brand Name : HARVONI

Dosage Form : TABLET;ORAL

Dosage Strength : 90MG;400MG

Packaging :

Approval Date : 2014-10-10

Application Number : 205834

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LEDIPASVIR; SOFOSBUVIR

Brand Name : HARVONI

Dosage Form : TABLET;ORAL

Dosage Strength : 45MG;200MG

Packaging :

Approval Date : 2019-08-28

Application Number : 205834

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LEDIPASVIR; SOFOSBUVIR

Brand Name : HARVONI

Dosage Form : PELLETS;ORAL

Dosage Strength : 33.75MG;150MG/PACKET

Packaging :

Approval Date : 2019-08-28

Application Number : 212477

Regulatory Info : RX

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LEDIPASVIR; SOFOSBUVIR

Brand Name : HARVONI

Dosage Form : PELLETS;ORAL

Dosage Strength : 45MG;200MG/PACKET

Packaging :

Approval Date : 2019-08-28

Application Number : 212477

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Several substances refer to content

Brand Name : Harvoni

Dosage Form : FILM COATED PILL

Dosage Strength : 90 MG / 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ledipasvir; Sofosbuvir

Brand Name : Harvoni

Dosage Form : Ledipasvir+Sofosbuvir+40090 Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 90 mg + 400mg bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sofosbuvir; Ledipasvir

Brand Name : Harvoni

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 90MG; 400MG

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LEDIPASVIR

Brand Name : HARVONI

Dosage Form : TABLET

Dosage Strength : 90MG

Packaging : 28

Approval Date :

Application Number : 2432226

Regulatory Info : Prescription

Registration Country : Canada

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ledipasvir

Brand Name : HARVONI

Dosage Form : FCT

Dosage Strength : 90mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Sofosbuvir; Ledipasvir

Brand Name : ZIFAM SOVIR PLUS

Dosage Form : Tablet

Dosage Strength : 400MG; 90MG

Packaging : Jar pack of 28's

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank